baber/WOPTO huggingface dataset:
Patent DE-04026812-T1 (DE)
Title: Metalllegierungen für die reflektierende oder semireflektierende Schicht eines optischen Speichermediums
Inventor: NEE HAN
IPC: G11B7/24038
Filed: 2001-05-04
Abstract: Optisches
Speichermedium, umfassend:  – eine erste Schicht (214;
314, 318) mit einem Muster von Merkmalen (215; 315, 319) in mindestens
einer Hauptfläche
sowie  – eine
erste Beschichtung (216; 316, 320) benachbart zur ersten Schicht,
wobei die erste Beschichtung semireflektierend ist und eine erste
metallische Legierung enthält,
wobei die erste metallische Legierung eine silberreiche Legierung ist,
welche zusätzlich
zu Silber mindestens ein Legierungselement umfasst, das aus der
Gruppe gewählt
ist, welche aus Kupfer, Indium, Zinn, Titan, Kadmium, Lithium, Nickel, Zirkon,
Chrom, Antimon, Gallium, Silizium, Bor, Molybdän und Mischungen hiervon besteht.
Patent DE-08009573-T1 (DE)
Title: Spritzenstößelanordnung und -trommel
Inventor: SHAW THOMAS J
IPC: A61M5/32
Filed: 1998-04-13
Abstract: Spritzenbaugruppe,
die eine einziehbare Nadel aufweist, die nach einer einzelnen Injektion
von Fluid in einen Patienten unbrauchbar gemacht wird, wobei die
Baugruppe umfasst:  einen hohlen Spritzenkörper, der einen Zylinder umfasst und
einen vorderen Endabschnitt sowie einen hinteren Endabschnitt aufweist,
wobei der hintere Endabschnitt des Weiteren wenigstens ein sich
radial erstreckendes Element umfasst, das Fingergriffe für den Spritzenkörper bereitstellt;  einen
Einziehmechanismus, der in dem vorderen Endabschnitt angeordnet
ist, wobei der Einziehmechanismus des Weiteren einen Nadelhalter
mit einem Kopfabschnitt, einem länglichen
Nadelhalteabschnitt und einem in Längsrichtung verlaufenden Fluidkanal
durch den Kopfabschnitt und den länglichen Nadelhalteabschnitt
hindurch umfasst, der Kopfabschnitt des Weiteren einen inneren Kopf,
ein durchgehendes Rückhalteelement,
das den inneren Kopf umgibt, sowie einen Überbrückungsabschnitt umfasst, der zwischen
dem durchgehenden Rückhalteelement
und dem inneren Kopf angeordnet ist, wobei der Überbrückungsabschnitt das durchgehende
Rückhalteelement
und den inneren Kopf miteinander verbindet, um eine Fluiddichtung
zwischen dem Fluidkanal und dem Zylinder vor dem...
Patent DE-08851028-T1 (DE)
Title: Verwendung von crth2-antagonisten-verbindungen
Inventor: HUNTER MICHAEL
IPC: A61P37/08
Filed: 2008-11-13
Abstract: Verbindung der allgemeinen Formel (I):  Darin ist:  R 1  C 1 -C 6 -Alkyl;  R 2  Halogen und  R 3  Aryl oder Heteroaryl, das optional durch ein oder mehrere Substituenten substituiert sein kann, die aus Halo, OH, CN, R 6 , COR 6 , CH 2 R 6 , OR 6 , SR 6 , SO 2 R 6  oder SO 2 YR 6  ausgewählt sind;  R 6  ist C 1 -C 6 -Alkyl, C 3 -C 8 -Cycloalkyl, Heterocyclyl, Aryl oder Heteroaryl, wobei ein beliebiger dieser Reste durch einen oder mehrere aus Halo, OH, CN, NO 2 , C 1 -C 6 -Alkyl oder O(C 1 -C 6 -Alkyl) ausgewählte Substituenten substituiert sein kann; und  Y ist NH oder eine gerade oder verzweigte C 1 -C 4 -Alkylenkette;  R 4  ist H oder C 1 -C 4 -Alkyl;  R 5  ist Wasserstoff, C 1 -C 6 -Alkyl, Aryl, (CH 2 ) m OC(=O)C 1 -C 6 -Alkyl, ((CH 2 ) m O) n CH 2 CH 2 X, (CH 2 ) m (N(R 7 ) 2  oder CH((CH 2 ) m O(C=O)R 8 ) 2 ;  m ist 1 oder 2;  n ist 1–4;  X ist OR 7  oder N(R 7 ) 2 ;  R 7  ist Wasserstoff oder Methyl;  R 8  ist C 1 -C 18 -Alkyl  oder ein pharmazeutisch zulässiges Salz, Hydrat, Solvat oder ein Komplex davon;  zur Behandlung eines allergischen Zustands, der durch die...
Patent DE-11869765-T1 (DE)
Title: Verfahren zur Ultraschall-Hohlraumbehandlung flüssiger Medien
Inventor: GINIYATULLIN MARAT MUNIROVICH
IPC: A23L5/30
Filed: 2011-09-21
Abstract: Verfahren zur Ultraschall-Kavitationsbehandlung flüssiger Medien, das eine etappenweise Einwirkung in Form von akustischer Kavitation umfasst, die aufgrund eines Doppelresonanzeffektes und der Bildung von stehenden Wellen innerhalb des mechanischen Durchflusssystems, eines Kanals mit Rechteckquerschnitt entsteht, dadurch gekennzeichnet, dass die akustische Kavitation gleichzeitig auf zwei oder mehreren unterschiedlichen Frequenzen gebildet wird, wobei der Kanal als nacheinander angeordnete Membranen ausgeführt ist, die unterschiedliche Frequenzen der ersten Schwingungsoberwelle haben, und die Erzeugung von Schallschwingungen mit der Stehwellenbildung gleichphasig an gegenüberliegenden Kanalseiten erfolgt, die ihrerseits im Abstand zwischen den Kanalwänden quasi-flache stehende Wellen bilden, die den Schwingungsfrequenzen der Membranen entsprechen, wobei die Kanalweite h als durch ein Viertel der Wellenlänge der im gegebenen behandelten flüssigen Medium für die benutzten Frequenzen angeregten Wellenlänge gewählt wird: h = (k/4)·(C/fi), k = 1, 2, 3, ...wobei fi Frequenzen der ersten Schwingungsoberwelle der Stehwellen der Membranen des Kanals, Hz; C die Schallgeschwindigkeit im flüssigen Medium, m/s; h der Abstand zwischen den Kanalwänden, m sind und wobei die Schwingungsamplitude der Kanalwand für unterschiedliche Behandlungsetappen des flüssigen Mediums angepasst wird und die Schwelle der akustischen Kavitation übersteigt.
Patent DE-12709826-T1 (DE)
Title: Verfahren zur Vorhersage der postoperativen Position einer IOL und Verwendung derartiger Verfahren
Inventor: OLSEN THOMAS
IPC: A61B3/10
Filed: 2012-03-08
Abstract: Verfahren zum Vorhersagen der postoperativen Position einer Ersatz-Intraokularlinse im Auge eines Patienten, wobei das Verfahren die folgenden Stufen umfasst: (i) Bestimmen der Position der bestehenden Lens cristallina im präoperativen Auge des Patienten; (ii) Bestimmen der Dicke der Lens cristallina im präoperativen Auge des Patienten und (iii) Vorhersagen der postoperativen Position der Intraokularlinse in Bezug auf die Position der Lens cristallina im präoperativen Auge des Patienten als Anteil der Dicke der Lens cristallina im präoperativen Auge des Patienten, wobei der Anteil durch eine einzige numerische Konstante (C), die durch den Intraokularlinsentyp bestimmt wird, definiert ist.
Patent DE-143631-T1 (DE)
IPC: F24H3/02
Filed: 1984-11-26
Abstract: An impingement oven wherein a carrier-type conveyor (30) passes between hot air plenums (18, 18; 19, 19) located above and below the conveyor. Horizontally adjacent plenums (18, 19) have their fans (22) located in an offset position to overhang the other one of the pair. Each plenum has a nozzle plate (20) to direct heated air toward the conveyor so that the air flow is substantially perpendicular to the conveyor and such workpiece(s) (5) as may be thereon. An oven module having four sets of plenums and four conveyors in the same enclosured is described. A plurality of such modules serially arranged provide a multizone oven. The oven is especially suited to heating flat workpieces of thermoplastic resin which are to be processed elsewhere into hollow objects such as containers.
Patent ES-2181610-T1 (ES)
Inventor: BRANDSTETTER JOSEF
IPC: B24D13/16
Filed: 2001-09-13
Abstract: A backing plate for an abrasive flap wheel has a sunk inner part and an outer flange. The sunk inner part has a hub which is provided with a location hole having an internal thread. The internal thread serves to fasten the backing wheel to the threaded shaft of a driving machine.
Patent CY-1106903-T1 (CY)
Inventor: TIHANYI KAROLY
IPC: A61P25/08
Filed: 2007-10-02
Abstract: The present invention relates to a pharmaceutical combination for the treatment of spasticity and/or pain characterized by that the combination contains as active ingredient 70-95% w/w compound of formula (I), wherein R represents a methyl or ethyl group, and 5-30% w/w dextromethorphan (chemical name: (+/-)-3-methoxi-17-methylmorphinan).
Patent CY-1108945-T1 (CY)
Inventor: MEYER JÖRG
IPC: C07K7/08
Filed: 2009-03-31
Abstract: The invention relates to compounds of formula (I) B-Q-X<SUB>1</SUB>, wherein B is a bioactive, cell adhesive mediating molecule, selected from the group (i) and Thr-Trp-Tyr-Lys-Ile-Ala-Phe-Gln-Arg-Asn-Arg-Lys (SEQ ID NO: 1) (ii), Trp-Tyr-Lys-Ile-Ala-Phe-Gln-Arg-Asn-Arg-Lys (SEQ ID NO: 2) (iii), Tyr-Lys-Ile-Ala-Phe-Gln-Arg-Asn-Arg-Lys (SEQ ID NO: 3) (iv), Thr-Trp-Tyr-Lys-Ile-Ala-Phe-Gln-Arg-Asn-Arg (SEQ ID NO: 4) (v), Thr-Trp-Tyr-Lys-Ile-Ala-Phe-Gln-Arg-Asn (SEQ ID NO: 5) (vi), Thr-Trp-Tyr-Lys-Ile-Ala-Phe-Gln-Arg (SEQ ID NO: 6) (vii), wherein (i) X, Y, Z, R<SUP>2</SUP>, R<SUP>3</SUP>, R<SUP>4</SUP>, A, Ar, Hal, Het, Het<SUP>1</SUP>, n, m, o, p, q, s, t have the meanings cited in claim 1 , Q is absent or is an organic spacer molecule, X<SUB>1 </SUB>is an anchor molecule selected from the group cited in claim 1 , and the salts thereof, which can be used as integrin inhibitors particularly for treatment of illness, deficiencies and inflammations caused by implants and osteolytic illnesses such as osteoporosis, thrombosis, cardiac infarction and arteriosclerosis, in addition to the acceleration and strengthening of the integration process of implants or the biocompatible surface in tissue.
Patent CY-1109028-T1 (CY)
Title: Νεα πεπτιδια τα οποια συνδεονται με τον υποδοχεα της ερυθροποιητινης
Inventor: HOLMES CHRISTOPHER P
IPC: A61K38/00
Filed: 2009-04-28
Abstract: Η παρούσα εφεύρεση αναφέρεται σε πεπτιδικές ενώσεις οι οποίες είναι συναγωνιστές του υποδοχέα της ερυθροποιητίνης (EPO-R). Η εφεύρεση αναφέρεται επίσης σε θεραπευτικές μεθόδους που χρησιμοποιούν τέτοιες πεπτιδικές ενώσεις για την αγωγή διαταραχών σχετιζόμενων με την ανεπαρκή ή ελαττωματική παραγωγή ερυθρών αιμοσφαιρίων. Παρέχονται επίσης φαρμακευτικές συνθέσεις, οι οποίες περιλαμβάνουν τις πεπτιδικές ενώσεις της εφευρέσεως.
Patent CY-1109098-T1 (CY)
Inventor: SMITH EDWARD ROBERT
IPC: A61M5/24
Filed: 2009-05-27
Abstract: A particle cassette for a needleless syringe is provided, the manufacture of which avoids the potentially detrimental use of heat when affixing a final membrane to the cassette or otherwise sealing the cassette after a filling procedure has been carried out. The particle cassette is assembled using first and second cassette parts that are attachable together so as to create a chamber for the confinement of particles between two membranes. A third cassette part may be used to provide for a locking attachment of the first and second parts. A kit of parts for use in the manufacture of a particle cassette is also provided, as is a method of assembling a particle cassette. In certain cassette embodiments, one or both of the first and second cassette parts can be annular, tapered and/or have detents or recesses to provide for a snap fit.
Patent CY-1112416-T1 (CY)
Inventor: HOFFMAN JONATHAN
IPC: A63B21/02
Filed: 2011-08-05
Abstract: A portable device for performing exercises, including: two independent tracks with a physical connection between them, and a movable platform on each track. The device is adapted to enable a user to move the movable platform on both tracks simultaneously by exerting a physical force on each platform simultaneously, and the physical force required to move each platform by the same distance is independently controllable for each platform.
Patent CY-1114615-T1 (CY)
Title: Μεθοδος σχηματισμου μιας ενεσιμης ραδιενεργης συνθεσης εγκαψυλιωμενων εντος ανθρακα ραδιενεργων σωματιδιων
Inventor: BROWITT RODNEY JAMES
IPC: A61K103/10
Filed: 2013-10-15
Abstract: Μία μέθοδος για τον σχηματισμό μίας ενέσιμης ραδιενεργού σύνθεσης, όπου η μέθοδος περιλαμβάνει τα βήματα: (a) εναπόθεση μίας στερεής μορφής ενός τεχνητίου επί ενός χωνευτηρίου άνθρακα· (b) προθέρμανση της στερεής μορφής τεχνητίου προκειμένου να απομακρυνθεί ο φορέας· (c) αποδόμηση πλάσματος τεχνητίου και τμημάτων του χωνευτηρίου άνθρακα· (d) άφεση του άνθρακα και του μετάλλου τεχνητίου να συν-συμπυκνωθούν από την αέρια φάση, ώστε να παραχθεί ένα αερόλυμα σύνθετων νανοσωματιδίων εντός ενός αδρανούς αερίου· (e) διασπορά των σύνθετων νανοσωματιδίων εντός ύδατος, το οποίο περιέχει μια χαμηλή συγκέντρωση επιφανειοδραστικής ουσίας, χρησιμοποιώντας μια ηλεκτρική διάταξη καταβύθισης· (f) κλασματοποίηση μεγέθους της διασποράς νανοσωματιδίων δια διήθησης με υδρόφιλες μεμβράνες γνωστού μεγέθους πόρων.
Patent CY-1115654-T1 (CY)
Title: Συνθετικο ενδιαμεσο ενωσης οξαζολιου και μεθοδοι για παρασκευη αυτου
Inventor: YAMAMOTO AKIHIRO
IPC: C07D405/12
Filed: 2014-10-22
Abstract: Ένα αντικείμενο της παρούσας εφεύρεσης είναι να παρέχει μία μέθοδο για την παρασκευή μιας ένωσης οξαζολίου σε υψηλή απόδοση. Το αντικείμενο μπορεί να επιτευχθεί με μία ένωση που αντιπροσωπεύεται από τον Τύπο (11): όπου το R1 είναι άτομο υδρογόνου ή κατώτερη αλκύλ ομάδα, το R2 είναι 1-πιπεριδύλ ομάδα υποκατεστημένη στην 4-θέση με υποκατάστατη επιλεγόμενο από (Α1α) φαινόξυ ομάδα υποκατεστημένη επί της φαινύλ χαρακτηριστικής ομάδας με μία ή περισσότερες αλογονο-υποκατεστημένες κατώτερες αλκόξυ-ομάδες, (A1b) φαινοξυ-υποκατεστημένη κατώτερη αλκύλ ομάδα υποκατεστημένη επί της φαινύλ χαρακτηριστικής ομάδας με μία ή περισσότερες αλογονο-υποκατεστημένες κατώτερες-αλκύλ ομάδες, (A1c) φαινυλ-υποκατεστημένη κατώτερη αλκοξυ-κατώτερη-αλκύλ ομάδα υποκατεστημένη επί της φαινύλ χαρακτηριστικής ομάδας με αλογόνο, (A1d) φαινυλ-υποκατεστημένη κατώτερη αλκύλ ομάδα υποκατεστημένη επί της φαινύλ χαρακτηριστικής ομάδας με μία ή περισσότερες αλογονα-υποκατεστημένες κατώτερες-αλκόξυ-ομάδες, (A1e) άμινο ομάδα υποκατεστημένη με φαινύλ ομάδα υποκατεστημένη με μία ή περισσότερες αλογονο-υποκατεστημένες κατώτερες-αλκόξυ ομάδες και κατώτερη-αλκύλ ομάδα και (A1f) φαινύλ-υποκατεστημένη κατώτερη-αλκόξυ ομάδα υποκατεστημένη επί της φαινύλ χαρακτηριστικής ομάδας με μία ή περισσότερες αλογονο-υποκατεστημένες κατώτερες-αλκόξυ ομάδες, το n είναι ακέραιος από 1 έως 6 και το Χ3 είναι οργανική σουλφονυλόξυ ομάδα.
Patent CY-1123221-T1 (CY)
Title: Ενωσεις θειαζολιδιου για αντιμετωπιση ιογενων λοιμοξεων
Inventor: ROSSIGNOL JEAN FRANCOIS
IPC: A61K45/06
Filed: 2020-08-06
Abstract: Ενώσεις θειαζολιδίου, όπως νιταζοξανίδη και/ή τιζοξανίδη, μπορούν να χρησιμοποιηθούν έναντι ιών που ανήκουν στην οικογένεια Picornaviridae ή στην οικογένεια Paramyxoviridae.
Patent CY-1123509-T1 (CY)
Title: Αλατα και στερεες μορφες ενος αντιβιοτικου μονοβακταμης
Inventor: AUBIN ERIC
IPC: C07D417/14
Filed: 2020-09-07
Abstract: Παρέχονται νέες στερεές μορφές, άλατα και πολύμορφα του 1-(((Ζ)-(1-(2-αμινοθειαζολ-4-υλο}-2-οξο-2-(((3S,4R)-2-οξο-4-((2-οξοοξαζολιδιν-3-υλο)μεθυλ)-1-σουλφοαζετιδιν-3-υλο)αμινο)αιθυλιδενο)αμινο)οξυ)-κυκλοπροπανοκαρβοξυλικού οξέος (αναφέρεται εδώ ως ένωση Χ), φαρμακευτικές συνθέσεις που τα περιέχουν, και διαδικασίες για την παρασκευή και χρήση τους στη θεραπεία.
Patent HR-P20090378-T1 (HR)
Title: Device and method for manufacturing profiles
Inventor: ENOECKL WALTER
IPC: B26D3/08
Filed: 2009-07-03
Abstract: The method involves rolling a surface finished sheet metal strip (1) applied with protection layer (2). The protection layer, arranged on the metal strip, is partly cut in the predetermined areas. The cutting of the protection layer is carried out with a cutting line, which moves perpendicularly on the surface of the metal strip. The cutting line runs partly inclined to a transport device of the metal strip. The metal strip is rolled to a profile strand. An independent claim is also included for a profile system with a line arranged roll pair.
Patent SI-1292293-T1 (SI)
Title: Stabilized pharmaceutically effective composition and pharmaceutical formulation comprising the same
Inventor: PFLAUM ZLATKO
IPC: A61K31/404
Filed: 2000-06-09
Abstract: Lovastatin, pravastatin, simvastatin, mevastatin, atorvastatin, and derivatives and analogs thereof are known as HMG-CoA reductase inhibitors and are used as antihypercholesterolemic agents. The majority of them are produced by fermentation using microorganisms of different species identified as species belonging to Aspergillus, Monascus, Nocardia, Amycolatopsis, Mucor or Penicillium genus, and some are obtained by treating the fermentation products using the methods of chemical synthesis or they are the products of total chemical synthesis.The aforementioned active substances may be destabilized by the environmental factors, their degradation may also be accelerated by interactions with other pharmaceutical ingredients, such as fillers, binders, lubricants, glidants and disintegrating agents, therefore the pharmaceutical ingredients and the process for preparation of the pharmaceutical formulation should be meticulously chosen to avoid the aforementioned undesired interactions and reactions.The present invention relates to a HMG-CoA reductase inhibitor which is stabilized by forming a homogeneous composition with a buffering substance or a basifying substance. This homogeneous composition is suitably used as the active substance in a pharmaceutical formulation for the treatment of hypercholesterolemia and hyperlipidemia.
Patent SI-1691805-T1 (SI)
Title: The use of urocanic acid being able to acidify the cell cytoplasm and for preventing or halting cellular proliferation in a person
Inventor: LEINO LASSE
IPC: A61K31/415
Filed: 2004-11-26
Abstract: The use of urocanic acid or another pharmaceutically acceptable agent being able to acidify the cell cytoplasm for the manufacture of a pharmaceutical composition useful for causing inhibition or halting of transformed or non-transformed cell proliferation in a person or an animal, where an effective amount of the agent is administered in an essentially non-dissociated form to the person or animal. The use of the agent as an enhancer for other therapeutically active agents, and a pharmaceutical composition, are also disclosed.
Patent SI-1685103-T1 (SI)
Title: 3-aminopyrrolidone derivatives
Inventor: THALER FLORIAN
IPC: A61K31/00
Filed: 2004-11-16
Abstract: This invention is related to compounds and use of 3-aminopyrrolidone derivatives and analogues of the following general formula (I) <CHEM> wherein  m is an integer from 1 to 3 X is methylene, oxygen, sulphur or a NR<6> group; R<1>   is a straight or branched C1-C8 alkyl or C3-C8 alkenylene or C3-C8 alkynylene chain, optionally substituted with CF3, phenyl, phenoxy or naphthyl, the aromatic rings optionally substituted by one or more C1-C4 alkyl, halogens, trifluoromethyl, hydroxy or C1-C4 alkoxy groups; R<2>, R<3>   are independently hydrogen, a C1-C3 alkyl chain, halogen, trifluoromethyl, hydroxy or C1-C4 alkoxy groups; R<4>, R<5>, R<6>   are independently hydrogen or C1-C6 alkyl;  and the pharmaceutically acceptable salts thereof that are active as sodium and/or calcium channel modulators and therefore useful in preventing, alleviating and curing a wide range of pathologies, including, but not limited to, neurological, psychiatric, cardiovascular, inflammatory, ophthalmic, urologic, metabolic and gastrointestinal diseases, where the above mechanisms have been described as playing a pathological role.
Patent SI-1651263-T1 (SI)
Title: Safe mutant viral vaccines
Inventor: WELCH SIAO-KUN WAN
IPC: C07K14/18
Filed: 2004-07-26
Abstract: The present invention provides safe vaccines and methods of preparing such vaccines. The vaccines of the present invention contain at least two live mutant viruses of the same family or nucleic acid molecules encoding such viruses, wherein each of the two viruses or the encoding nucleic acids contains a mutation that confers a desirable phenotype and the mutations in the viruses reside in the same genomic site such that the mutant viruses cannot recombine with each other to eliminate the mutations.
Patent SI-2161273-T1 (SI)
Title: Imidazo(4,5-c)pyridine compounds and methods of antiviral treatment
Inventor: PUERSTINGER GERHARD
IPC: C07D471/00
Filed: 2004-12-21
Abstract: The present invention relates to pharmaceutical compositions for the treatment or prevention of viral infections comprising as an active principle at least one imidazo[4,5-c]pyridine prodrug having the general formula (A):   
wherein the substituents are described in the specification.  The invention also relates to processes for the preparation and screening of compounds according to the invention having above mentioned general formula and their use in the treatment or prophylaxis of viral infections.
Patent SI-1843757-T1 (SI)
Title: Phantom phenomena treatment
Inventor: KNIPPER-BREER MARLIES
IPC: A61P25/00
Filed: 2006-01-19
Abstract: Use of a compound (I) interacting with brain-derived nerve growth factor (BDNF)-signal transduction cascade for the production of a medicament to treat phantom phenomena of acute tinnitus and/or phantom pain in human or animal. Independent claims are also included for: (1) diagnosing phantom phenomena of the acute tinnitus and/or phantom pain in human or animal, comprising supplying a biological sample, determining the level of the expression of BDNF in the biological sample, comparing the level with a reference value from a healthy organism, and correlating a level lying over the healthy organism with a positive diagnosis; and (2) treating phantom phenomena of the acute tinnitus and/or phantom pain in human or animal, comprising supplying a medicament that exhibits a substance interacting with BDNF signal transduction cascade, and applying the medicament locally to the organism, and optionally repeating the method. ACTIVITY : Auditory; Analgesic. MECHANISM OF ACTION : Brain-derived nerve growth factor (BDNF)-signal transduction cascade blocker; BDNF-signal transduction cascade inhibitor; Gamma aminobutyric acid receptor agonist; L-type-Ca ++>-channel antagonist; Cyclic adenosine monophosphate response element binding protein (CREP) antagonist; Glutamate antagonist; Mitogen activated protein-kinase-inhibitor; Calmodulin-dependent kinase-inhibitor; Tyrosine kinase linked receptor (trkB) antagonist. The ability of (I) to inhibit BDNF-signal transduction cascade was tested in cochlea. (I) Significantly removed the expressions of BNDF Exon-IV.
Patent SI-2145445-T1 (SI)
Title: Method for improving a tcp data transmission process in case the physical transmission medium is disconnected
Inventor: KLEO REMI
IPC: H04L69/40
Filed: 2008-02-28
Abstract: A method for the improvement of a TCP data transmission process in the case of an interruption of the physical transmission medium, wherein after the establishment of a TCP connection between a client (10) and a server (12) a data packet is transmitted from the server (12) to the client (10), wherein the receipt of the data packet from the server (12) is confirmed by the client (10) by the transmission of a confirmation message assigned to the received data packet, ACK message, wherein in the case of the transmission of the ACK message at the client (10) a timer (14) is started with a default time T1, and the same ACK message is repeatedly transmitted to the server (12), in case no further data packet has been received from the server (12) at the client (10) after expiration of the time T1.
Patent SI-2517265-T1 (SI)
Title: Solar panel comprising a printed circuit and method of production and use thereof
Inventor: BATTISTUTTI RENE
IPC: H02S40/00
Filed: 2010-12-23
Abstract: The invention relates to a solar panel, consisting of a plurality of photovoltaic cells or a plurality of photovoltaic cell strings which in turn consist of a plurality of series-connected photovoltaic cells, wherein the photovoltaic cell strings can be connected in series and/or in parallel and are laminated between a front glass substrate and a backing film or a backing glass substrate using adhesive composite films or other encapsulating materials. At least the photovoltaic cell strings are wired by a circuit board and said circuit board is arranged in the laminated composite on the level of the photovoltaic cells at the edge of the panel. The panels are connected to the photovoltaic system from said circuit board either at the back or laterally or laterally on the panel edge through a cut-out section in the backing film or the backing glass substrate. The invention further relates to a method for producing a solar panel, the circuit board being electrically connected to the photovoltaic cells or the photovoltaic cell strings and being laminated together on the level of the photovoltaic cells between a front glass substrate and a backing film or a backing glass substrate using a lamination device. The panels are connected at the back or laterally via direct contacts to the circuit board. The panels are used for the direct conversion of solar energy to electrical energy.